You are in: eMedicine Specialties > Medicine, Ob/Gyn, Psychiatry, and Surgery > Infectious Diseases
|
Q Fever Last Updated: March 5, 2004 |
|
| Synonyms and related keywords: Coxiella burnetii, C burnetii, zoonosis, zoonotic transmission, farm animals, livestock, bacterial infection, farm infection, chronic Q fever, chronic fatigue syndrome |
|   |
AUTHOR INFORMATION
| Section 1 of 10  |
|
| Author: Annie Ruest, MD, Infectious Diseases Fellow, Department of Infectious Diseases and Clinical Microbiology, Centre Hospitalier Universitaire De Sherbrooke, Canada Coauthor(s): Christian P Sinave, MD, FRCPC, Associate Professor, Department of Medical Microbiology and Infectious Diseases, University of Sherbrooke, Canada |
| Annie Ruest, MD, is a member of the following medical societies:
American Society for Microbiology |
| Editor(s): John M Leedom, MD, Professor of Medicine, Keck School of Medicine, University of Southern California; Chief, Division of Infectious Diseases, Department of Internal Medicine, Los Angeles County, University of Southern California Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine;
Joseph F John, Jr, MD, FACP, FIDSA, FSHEA, Professor of Medicine, Molecular Genetics and Microbiology, Medical University of South Carolina, Associate Chief of Staff for Education, Ralph H Johnson Veteran's Administration Medical Center;
Eleftherios Mylonakis, MD, PhD, Assistant Professor of Medicine, Harvard Medical School, Assistant in Medicine, Division of Infectious Disease, Massachusetts General Hospital;
and Burke A Cunha, MD, MACP, Professor of Medicine, State University of New York School of Medicine at Stony Brook; Chief, Infectious Disease Division, Winthrop-University Hospital |
Disclosure
|   |
INTRODUCTION
| Section 2 of 10  |
|
Background: Q fever is a zoonosis caused by a strictly intracellular pathogen, Coxiella burnetii. It occurs worldwide, with the exception of New Zealand. The suspicion of a new disease was first made by Derrick in 1935 during a cluster of acute febrile illness in abattoir workers of Queensland, Australia, hence the name of Q fever (for query). The causative organism was later isolated from Derrick's patients by Burnet and Freeman. In the meantime, Davis and Cox isolated a similar organism from ticks. In 1938, these organisms were recognized as the same and named Coxiella burnetii.
The reservoir of the disease primarily is farm animals (eg, cattle, goats, sheep), but domestic animals also are implicated. C burnetii is excreted in urine, milk, and feces and attains high concentration in birth products. It is extremely resistant because of its sporelike life cycle. Rare human-to-human transmission has been described from exposure to the placenta of an infected woman and from blood transfusions. The possibility of sexual transmission also exists. Pathophysiology: First thought to be a Rickettsia, C burnetii is now classified within the gamma group of proteobacteria. It is a gram-negative bacterium that is acquired most often via inhalation of aerosols. The possibility of becoming infected by ingesting contaminated raw milk exists but has not yet been confirmed. In the lungs, it proliferates in macrophages (in the acidic phagolysosome vacuole) and then gains access to the blood, producing a transient bacteremia. Thereafter, it can invade many organs but most frequently invades the lungs and liver. Immune responses result in inflammation manifested by granulomas in the liver, spleen, and bone marrow, and are the classic doughnut granulomas. They disappear with convalescence.
C burnetii undergoes phase variation. Phase I antigens occur in animals and in nature and are highly infectious. Phase II antigens are those obtained after subculture and are not infectious. In the acute form of the disease, antiphase II antibodies are elevated. The chronic form is characterized by an augmentation of both antiphase I and antiphase II antibodies. Immunity is due to cellular immune response. Accordingly, a patient with defects in cellular immunity is more prone to develop the chronic form of the disease. Frequency:
- In the US: Prevalence of Q fever is extremely difficult to assess because it usually is not a reportable disease and because of surveillance bias. The disease was reported to be endemic to California during the 1950s.
- Internationally: In certain regions of France and Spain, the organism is highly prevalent, being the second most common etiology of community-acquired pneumonia and causing 5-8% of endocarditis cases. Multiple reports of clusters have been described for many years. A few clusters were reported in the province of Nova Scotia, Canada and were related to exposure through parturient cats.
Mortality/Morbidity: Acute Q fever most often is self-limited illness, but the chronic form, with its most common cause, endocarditis, carries mortality rates that can exceed 60%.
Sex: No particular susceptibility to Q fever has been related to sex. However, a predominance of male infections has been reported in regions where a cattle-type reservoir is present, mainly due to occupational trends. Pregnant women seem to be predisposed to the chronic form of the disease and to reactivation during subsequent pregnancies.
Age: Where cattle are the reservoir, a predominance in active men aged 25-40 years has been noted.
|   |
CLINICAL
| Section 3 of 10  |
|
History: - Acute Q fever: Sixty percent of affected patients will have an asymptomatic infection. The incubation period varies from 2-6 weeks. Three main clinical presentations are described for acute Q fever, as follows:
- The first is a self-limited febrile illness, which often is accompanied by headache, myalgia, and chills, with an abrupt onset.
- The second, pneumonia, most frequently is atypical, rarely fulminant, and progresses to acute respiratory distress syndrome. It also can be found incidentally upon chest x-ray examination.
- The third, hepatitis, often is associated with smooth-muscle and antiphospholipid or antinuclear antibodies. Patients rarely have gastrointestinal symptoms. Pericarditis, myocarditis, meningoencephalitis, abortion, and dermatologic manifestations are less commonly associated. Thyroiditis, mediastinal lymphadenopathy, pancreatitis, mesenteric panniculitis, epididymitis, orchitis, priapism, inappropriate secretion of antidiuretic hormone, optic neuritis, Guillain-Barré syndrome, and extrapyramidal neurological disease are rare. Symptoms include fever (88-100%), fatigue (97-100%), myalgia (47-69%), chills (68-88%), sweats (31-98%), headache (68-98%), dry cough (24-90%), confusion, pleuritic chest pain, dyspnea, nausea, vomiting, and diarrhea.
- Chronic Q fever: Several manifestations of chronic Q fever are described, as follows:
- Endocarditis is the main clinical presentation, usually occurring in patients with cardiac valve defects. Immunocompromised patients (AIDS, renal failure, hematologic cancer) also are susceptible. Patients present with heart failure or with nonspecific symptoms, including low-grade fever, fatigue, chills, arthralgia, and night sweats.
- Other manifestations include vascular (infections of aneurysms or grafts), osteoarticular (osteomyelitis, coxitis, spondylodiscitis, arthritis), obstetric (spontaneous abortion, premature labor, due to placentitis), hepatic (chronic hepatitis), pulmonary (interstitial fibrosis, pseudotumor), and renal (glomerulonephritis) complications. Q fever could be added to the organisms of the TORCH syndrome (toxoplasmosis, other infections, rubella, cytomegalovirus infection, and herpes simplex), and chronic fatigue syndrome also has been described following acute Q fever.
Physical: - Pneumonia signs include high-grade fever and inspiratory crackles; less frequently, patients present with signs of consolidation or pleural effusion.
- Hepatitis presents with hepatomegaly and jaundice (rarely).
- Meningeal signs, pericardial rub, and maculopapular or petechial rash also may appear.
- Chronic Q fever: Endocarditis manifests with low-grade fever (or no fever), augmentation of a known heart murmur, signs of heart failure, hepatosplenomegaly, clubbing, and signs of embolic complications.
Causes: - Q fever most often is related to animal exposure. However, because of the particular resistance to Coxiella in nature as a spore, it can infect people with no known contact with animals. For example, an outbreak was reported in people living along a road on which farm vehicles contaminated with straw and manure traveled.
|   |
DIFFERENTIALS
| Section 4 of 10  |
|
Abortion Chronic Fatigue Syndrome Fever of Unknown Origin Infective Endocarditis Meningitis Myocarditis Pericarditis, Acute
Other Problems to be Considered:
Infectious hepatitis
Placentitis
Atypical pneumonia
Vascular graft infections
Osteomyelitis |
|
Patient Education
|
|
Click here for patient education.
|
|
|
|
|
|   |
WORKUP
| Section 5 of 10  |
|
Lab Studies:
- Complete blood count findings usually show normal white blood cells, mild thrombocytopenia, hemolytic anemia (rarely), elevated transaminases, elevated alkaline phosphatase, anti–smooth-muscle antibodies, and circulating anticoagulant and antiphospholipid antibodies.
- Cerebrospinal fluid examination with meningoencephalitis shows an elevated white blood cell count (monocytes), increased protein concentration, and normal glucose.
- Serology is the criterion standard for diagnosis. Molecular techniques and cultures are available only in reference laboratories. Three serological techniques are used, microimmunofluorescence, complement fixation, and enzyme-linked immunosorbent assay (ELISA).
- Complement fixation has been used extensively, with antiphase II antibody titers greater than or equal to 40 being indicative of acute Q fever. A 4-fold increase between acute and convalescent serum titers also has been used to indicate the diagnosis.
- Microimmunofluorescence is now the reference method, with immunoglobulin G (IgG) antiphase II antibody titers greater than or equal to 200 and immunoglobulin M (IgM) antiphase II antibody titers greater than or equal to 50 indicating the presence of acute disease. Results of serology are positive 2-4 weeks after the onset of symptoms. Titers less than or equal to 100 make the diagnosis of acute Q fever unlikely.
- ELISA recently was compared to immunofluorescence and the complement fixation test, the immunofluorescence being the reference method. ELISA was found to be significantly more sensitive but slightly less specific than the complement fixation test.
- Blood test findings are as follows:
- Elevated sedimentation rate
- Elevated gamma globulins (polyclonal)
- Rheumatoid factor
- Anemia
- Increased creatinine
- Negative conventional blood cultures
- Serology findings are as follows:
- With the complement fixation test, antiphase I antibody titers greater than or equal to 200 indicate chronic disease.
- With the microimmunofluorescence test, the presence of antiphase I antibodies indicates chronic Q fever, and IgG antiphase I antibody titers greater than or equal to 800 are highly predictive of endocarditis.
Imaging Studies:
- Chest x-ray frequently shows abnormalities that are segmental or lobar opacities. Multiple round opacities and pleural effusion also can be seen.
- Echocardiogram shows pericardial effusion with pericarditis.
- Chest x-ray reveals signs of interstitial fibrosis and pseudotumor.
- Echocardiogram shows vegetations (rarely).
Other Tests:
- Acute Q fever: ECG shows T-wave abnormalities with myocarditis and pericarditis.
Histologic Findings: Classic doughnut granulomas (with central clearing and a fibrin ring) are observed in the liver and bone marrow but are not specific to Q fever because they also occur in Hodgkin lymphoma, typhoid fever, cytomegalovirus infection, infectious mononucleosis, and allopurinol hypersensitivity.
|   |
TREATMENT
| Section 6 of 10  |
|
Medical Care: - Acute Q fever: The symptoms of acute Q fever usually resolve spontaneously within 2 weeks, but antibiotic treatment has been shown to reduce the duration of disease. The optimal duration of treatment has never been adequately studied. Antibiotics are given for 14-21 days, usually in an outpatient setting. Treatment is described as follows:
- Doxycycline is the treatment of choice.
- Fluoroquinolones are good alternatives. Ofloxacin and pefloxacin have been used with success in patients. New fluoroquinolones, moxifloxacin and levofloxacin, appeared even more potent in vitro.
- Quinolones are the treatment of choice in meningoencephalitis because of excellent cerebrospinal fluid concentration.
- Macrolides are alternatives, especially azithromycin and clarithromycin, but some strains of C burnetii could be resistant. Co-trimazole also could be used.
- No reliable regimen is available for children (<8 y) and pregnant women, but macrolides and co-trimazole probably should be tried.
- Hepatitis is characterized by a potent inflammatory syndrome with autoantibodies and frequently is unresponsive to antimicrobials. However, prednisone occasionally has been reported to benefit patients who show no clinical response after 3 days of antibiotics.
- Chronic Q fever: This is a very frustrating disease to treat. A combined antimicrobial regimen is recommended for a prolonged period of time. Hospitalization may be warranted for intractable heart failure. Treatment is described as follows:
- No drug used alone has been shown to be bactericidal for C burnetii. Therefore, combination therapy is recommended for a prolonged period of time because of the high rate of relapse with shorter treatment. No agreement has been reached on the ideal duration of therapy, but it should follow serology results.
- The most commonly used regimen consists of doxycycline with ofloxacin (or pefloxacin) for a minimum of 3 years.
- The more recently studied combination of doxycycline with hydroxychloroquine seems promising because one can reduce the duration of therapy to 18 months. The use of hydroxychloroquine is based on the assumption that it will elevate the pH within the phagolysosome vacuole of the monocyte, where C burnetii resides. It will thus perturb the metabolism of the organism and make the action of doxycycline easier, given the higher pH.
- The combination of rifampin with a fluoroquinolone is effective, but its interaction with anticoagulants is problematic.
Surgical Care: - This is reserved for intractable heart failure. C burnetii can persist on endocardial tissue even after valve replacement; therefore, antibiotics should be continued following surgery.
Consultations: - Infectious disease specialist
- Cardiothoracic surgeon for selected cases
|   |
MEDICATION
| Section 7 of 10  |
|
The goals of pharmacotherapy are to reduce morbidity and to prevent complications.
Drug Category: Antibiotics -- Drugs are used that provide in vivo activity in infections caused by C burnetii. Drug Name
| Doxycycline (Vibramycin) -- First-line agent for both acute and chronic diseases. Bacteriostatic drug that interferes with bacterial protein synthesis by binding to 30S ribosome. |
|---|
| Adult Dose | Acute Q fever: 100 mg PO bid for 14 d
Chronic Q fever: 100 mg PO bid for at least 3 y when combined with ofloxacin (or pefloxacin); 100 mg PO bid for at least 18 mo when combined with hydroxychloroquine| Pediatric Dose | <8 years: Contraindicated
>8 years: 2-4 mg/kg/d PO divided q 12 h| Contraindications | Documented hypersensitivity; pregnant women |
|---|
| Interactions | Antacids, milk, iron- or zinc-containing medications, didanosine, and sucralfate minimally diminish absorption; Tegretol and chronic ethanol ingestion decrease effects; reduces action of oral contraceptives; may potentiate effect of anticoagulants; BUN augmentation reported when used with diuretics |
|---|
| Pregnancy |
X - Contraindicated in pregnancy |
|---|
| Precautions | Adverse effects include photosensitivity (rare) and permanent tooth discoloration in children due to enamel hypoplasia |
|---|
|
|---|
|
|---|
Drug Name
| Ofloxacin (Floxin) -- An alternative to doxycycline in acute Q fever. A derivative of pyridine carboxylic acid with broad-spectrum bactericidal effect. |
|---|
| Adult Dose | Acute Q fever: 200 mg PO q8h for 14-21 d Chronic Q fever: 200 mg PO tid with doxycycline for at least 3 y |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity; pregnant women |
|---|
| Interactions | Antacids, sucralfate, and iron- or zinc-containing medications diminish absorption; increases risk of seizures when used with AINS drugs |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Dosage adjustment is required in renal failure; adverse effects include nausea, vomiting, abdominal discomfort and diarrhea, mild headache and dizziness, allergic rash, and photosensitivity; avoid in nursing mother (excreted in breast milk) |
|---|
Drug Category: Antimalarial drugs -- These agents are used for their alkalinizing action within the phagolysosomal compartment of monocyte, where C burnetii resides.Drug Name
| Hydroxychloroquine (Plaquenil) -- Used in chronic Q fever, with doxycycline, which is then more effective. Fewer relapses than with doxycycline and ofloxacin. Treatment duration can be shortened. |
|---|
| Adult Dose | 200 mg PO tid with doxycycline for at least 18 mo; dosage reduction to 200 mg PO bid or qd if gastrointestinal intolerance develops |
|---|
| Pediatric Dose | Not established |
|---|
| Contraindications | Documented hypersensitivity to drug or 4-aminoquinoline compounds; preexisting retinopathy |
|---|
| Interactions | Serum levels increase with cimetidine; magnesium trisilicate may decrease absorption |
|---|
| Pregnancy |
C - Safety for use during pregnancy has not been established.
|
|---|
| Precautions | Use with caution in hepatic or renal disease; adverse effects include retinopathy, corneal opacities, rash, pigmentation changes, alopecia, photosensitivity, nausea, diarrhea, abdominal pain; should be avoided in porphyria or psoriasis |
|---|
|   |
FOLLOW-UP
| Section 8 of 10  |
|
Further Outpatient Care:
- In chronic Q fever, follow-up serology and clinical assessment are recommended on a monthly basis during antimicrobial therapy and for the first 6 months following withdrawal, then every 6 months for 2 years, and once a year thereafter. Antiphase I IgG or immunoglobulin A (IgA) titers less than or equal to 200 are believed to indicate cure.
- Perform an echocardiogram every 3 months during antimicrobial therapy and every 6 months for the first 2 years following drug withdrawal.
- If hydroxychloroquine is used, an ophthalmologic follow-up evaluation is required to rule out retinal toxicity.
Deterrence/Prevention:
- Vaccine prophylaxis is available and currently is used in Australia. It should be used for people at risk, such as veterinarians, abattoir workers, farmers, or others in occupations requiring close contact with animals.
- Avoid ingestion of raw milk and exposure to birth products (eg, placenta).
Complications:
- Chronic fatigue syndrome is reported as a complication of acute Q fever, but only rarely.
- Chronic Q fever endocarditis can lead to severe heart failure.
- Reactivation of Q fever has been reported during pregnancy.
Prognosis:
- Acute Q fever is a self-limited disease.
- Chronic Q fever carries mortality rates that can exceed 60%. Frequent relapses (50%) are observed despite adequate therapy.
|   |
MISCELLANEOUS
| Section 9 of 10  |
|
Medical/Legal Pitfalls:
- Failure to obtain a specific serology in patients presenting with culture-negative endocarditis
- Failure to recognize specific host risk factors in patients with classic Q fever clinical presentations
|   |
BIBLIOGRAPHY
| Section 10 of 10 |
|
-
Boschini A, Di Perri G, Legnani D: Consecutive epidemics of Q fever in a residential facility for drug abusers: impact on persons with human immunodeficiency virus infection. Clin Infect Dis 1999 Apr; 28(4): 866-72[Medline].
-
Brouqui P, Dupont HT, Drancourt M: Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med 1993 Mar 8; 153(5): 642-8[Medline].
-
Carrascosa M, Pascual F, Borobio MV: Rhabdomyolysis associated with acute Q fever. Clin Infect Dis 1997 Nov; 25(5): 1243-4[Medline].
-
Domingo P, Munoz C, Franquet T: Acute Q fever in adult patients: report on 63 sporadic cases in an urban area. Clin Infect Dis 1999 Oct; 29(4): 874-9[Medline].
-
Fenollar F, Fournier PE, Carrieri MP: Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001 Aug 1; 33(3): 312-6[Medline].
-
Field PR, Mitchell JL, Santiago A: Comparison of a commercial enzyme-linked immunosorbent assay with immunofluorescence and complement fixation tests for detection of Coxiella burnetii (Q fever) immunoglobulin M. J Clin Microbiol 2000 Apr; 38(4): 1645-7[Medline].
-
Fournier PE, Casalta JP, Piquet P: Coxiella burnetii infection of aneurysms or vascular grafts: report of seven cases and review. Clin Infect Dis 1998 Jan; 26(1): 116-21[Medline].
-
Fournier PE, Etienne J, Harle JR: Myocarditis, a rare but severe manifestation of Q fever: report of 8 cases and review of the literature. Clin Infect Dis 2001 May 15; 32(10): 1440-7[Medline].
-
Fournier PE, Marrie TJ, Raoult D: Diagnosis of Q fever. J Clin Microbiol 1998 Jul; 36(7): 1823-34[Medline].
-
Gillis CM, ed: Compendium of Pharmaceuticals and Specialties. 34th ed. Ottawa, Ontario: Canadian Pharmacists Association; 1999: 471-2; 1398-9.
-
Graham JV, Baden L, Tsiodras S: Q fever endocarditis associated with extensive serological cross- reactivity. Clin Infect Dis 2000 Mar; 30(3): 609-10[Medline].
-
Korman TM, Spelman DW, Perry GJ: Acute glomerulonephritis associated with acute Q fever: case report and review of the renal complications of Coxiella burnetii infection. Clin Infect Dis 1998 Feb; 26(2): 359-64[Medline].
-
Kruszewska D, Lembowicz K, Tylewska-Wierzbanowska S: Possible sexual transmission of Q fever among humans. Clin Infect Dis 1996 Jun; 22(6): 1087-8[Medline].
-
Levy PY, Carrieri P, Raoult D: Coxiella burnetii pericarditis: report of 15 cases and review. Clin Infect Dis 1999 Aug; 29(2): 393-7[Medline].
-
Levy PY, Drancourt M, Etienne J: Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis. Antimicrob Agents Chemother 1991 Mar; 35(3): 533-7[Medline].
-
Lovey PY, Morabia A, Bleed D: Long term vascular complications of Coxiella burnetii infection in Switzerland: cohort study. BMJ 1999 Jul 31; 319(7205): 284-6[Medline].
-
Mandell GL, Bennett JE, Dolin R, eds: Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases. 5th ed. Philadelphia, Pa: Churchill Livingstone; 2000: 2043-50.
-
Marrie TJ, Raoult D: Q fever: a review and issues for the next century. International Journal of Antimicrobial Agents 1997; 8: 145-61.
-
Maurin M, Raoult D: Q fever. Clin Microbiol Rev 1999 Oct; 12(4): 518-53[Medline].
-
Maurin M, Raoult D: Bacteriostatic and bactericidal activity of levofloxacin against Rickettsia rickettsii, Rickettsia conorii, 'Israeli spotted fever group rickettsia' and Coxiella burnetii. J Antimicrob Chemother 1997 Jun; 39(6): 725-30[Medline].
-
Milazzo A, Hall R, Storm PA: Sexually transmitted Q fever. Clin Infect Dis 2001 Aug 1; 33(3): 399-402[Medline].
-
Musso D, Raoult D: Coxiella burnetii blood cultures from acute and chronic Q-fever patients. J Clin Microbiol 1995 Dec; 33(12): 3129-32[Medline].
-
Ordi-Ros J, Selva-O'Callaghan A, Monegal-Ferran F: Prevalence, significance, and specificity of antibodies to phospholipids in Q fever. Clin Infect Dis 1994 Feb; 18(2): 213-8[Medline].
-
Raoult D, Marrie T: Q fever. Clin Infect Dis 1995 Mar; 20(3): 489-95; quiz 496[Medline].
-
Raoult D, Houpikian P, Tissot Dupont H: Treatment of Q fever endocarditis: comparison of 2 regimens containing doxycycline and ofloxacin or hydroxychloroquine. Arch Intern Med 1999 Jan 25; 159(2): 167-73[Medline].
-
Raoult D: Treatment of Q fever. Antimicrob Agents Chemother 1993 Sep; 37(9): 1733-6[Medline].
-
Raoult D, Tissot-Dupont H, Foucault C: Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000 Mar; 79(2): 109-23[Medline].
-
Rolain JM, Maurin M, Raoult D: Bacteriostatic and bactericidal activities of moxifloxacin against Coxiella burnetii. Antimicrob Agents Chemother 2001 Jan; 45(1): 301-2[Medline].
-
Sawaishi Y, Takahashi I, Hirayama Y: Acute cerebellitis caused by Coxiella burnetii. Ann Neurol 1999 Jan; 45(1): 124-7[Medline].
-
Stein A, Raoult D: Q fever during pregnancy: a public health problem in southern France. Clin Infect Dis 1998 Sep; 27(3): 592-6[Medline].
-
Tolosa-Vilella C, Rodriguez-Jornet A, Font-Rocabanyera J: Mesangioproliferative glomerulonephritis and antibodies to phospholipids in a patient with acute Q fever: case report. Clin Infect Dis 1995 Jul; 21(1): 196-8[Medline].
Q Fever excerpt |